BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. TGFB1, Metabolism of xenobiotics, Leukemia, Intestine, Human chorionic gonadotropin)
Bookmark Forward

QuickView for FPR1 (gene)


Body Atlas

Most Correlated Tissues

  1. Neutrophil of bone marrow
  2. Leukocyte (polymorphonuclear) of peripheral blood
  3. Whole blood
  4. Macrophage of peripheral blood
  5. Mononuclear cell of peripheral blood
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Contact dermatitis
  2. Infection due to Staphylococcus aureus
  3. Acne
  4. Spotted fevers
  5. Ebola virus disease
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. benzamil
  2. Protriptyline
  3. Sulfacetamide
  4. Neupogen
  5. Transforming Growth Factor beta3
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. ERVK3-1
  2. TRIM6
  3. BZW2
  4. BZW1
  5. TAL2
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Formyl peptide receptor-1 (FPR1) represses intestinal oncogenesis.
  2. Knockout or treatment with an antagonist of formyl peptide receptor 1 protects mice from sepsis by i…
  3. Formyl Peptide Receptor 1 Inhibits Reparative Angiogenesis and Aggravates Neuroretinal Dysfunction i…
  4. Differential requirement of formyl peptide receptor 1 in macrophages and neutrophils in the host def…
  5. Formyl peptide receptor 1 is involved in surgery-induced neuroinflammation and dysfunction of learni…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Correlation of Formyl Peptide Receptor 1 With Sepsis-related Encephalopathy
  2. The Andromeda Study.Predictive Value of Combined Criteria to Tailor Breast Cancer Screening.
  3. A Study to Evaluate the Safety, Efficacy and Changes in Induced Sputum and Blood Biomarkers Followin…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.